AMENDMENT NO. 2 TO AMENDMENT NO. 6 TO THE ENBREL®SUPPLY AGREEMENTSupply Agreement |
|
|
You are currently viewing: This Supply Agreement involves
AMGEN INC | American Home Products Corporation | IMMUNEX CORPORATION | Wyeth Pharmaceuticals. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here. |
|
|
|
Search Supply Agreement by:
Exhibit 10.53
|
|
|
|
|
Note: |
|
Redacted portions have been marked with [*]. The redacted portions are subject to a request for confidential treatment that has been filed with the Securities and Exchange Commission. |
AMENDMENT NO. 2
TO
AMENDMENT NO. 6
TO THE
ENBREL ® SUPPLY AGREEMENT
This Amendment No. 2 to Amendment No. 6 (“Amendment No. 6.2”) is made this 26th day of August, 2008 (the “Amendment No. 6.2 Effective Date”) by and among IMMUNEX CORPORATION, a corporation of the State of Washington, having its principal place of business at One Amgen Center Drive, Thousand Oaks, California, 91320, U.S.A., together with its Affiliates (“Immunex”), WYETH (formerly known as American Home Products Corporation), a corporation of the State of Delaware having its corporate headquarters at Five Giralda Farms, Madison, New Jersey 07940, U.S.A. and acting through its Wyeth Pharmaceuticals Division (“Wyeth”), and BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG , a German corporation having a place of business at Birkendorfer Straße 65, 88397 Biberach an der Riss, Federal Republic of Germany (“BIP”), and amends the Enbrel Supply Agreement effective as of November 5, 1998, by and among Immunex, Wyeth, and BIP, and as amended (the “Agreement”).
WHEREAS, Immunex, Wyeth and BIP have entered into a certain Agreement for BIP’s supply of Enbrel ® (etanercept) to Immunex and Wyeth; and
WHEREAS, the Parties originally intended to transfer the manufacturing process to a Second Generation Pro
